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Am J Physiol Renal Physiol 302: F1034–F1044, 2012. First published
January 11, 2011; doi:10.1152/ajprenal.00371.2011.—The acyl-CoA
binding protein (ACBP) is a small intracellular protein that specifi-
cally binds and transports medium to long-chain acyl-CoA esters.
Previous studies have shown that ACBP is ubiquitously expressed but
found at particularly high levels in lipogenic cell types as well as in
many epithelial cells. Here we show that ACBP is widely expressed
in human and mouse kidney epithelium, with the highest expression in
the proximal convoluted tubules. To elucidate the role of ACBP in the
renal epithelium, mice with targeted disruption of the ACBP gene
(ACBP/) were used to study water and NaCl balance as well as
urine concentrating ability in metabolic cages. Food intake and uri-
nary excretion of Na and K did not differ between ACBP/
and / mice. Interestingly, however, water intake and diuresis were
significantly higher at baseline in ACBP/ mice compared with that
of / mice. Subsequent to 20-h water deprivation, ACBP/ mice
exhibited increased diuresis, reduced urine osmolality, elevated he-
matocrit, and higher relative weight loss compared with / mice.
There were no significant differences in plasma concentrations of
renin, corticosterone, and aldosterone between mice of the two geno-
types. After water deprivation, renal medullary interstitial fluid osmo-
lality and concentrations of Na, K, and urea did not differ between
genotypes and cAMP excretion was similar. Renal aquaporin-1
(AQP1), -2, and -4 protein abundances did not differ between water-
deprived / and ACBP/ mice; however, ACBP/ mice dis-
played increased apical targeting of pS256-AQP2. AQP3 abundance
was lower in ACBP/ mice than in / control animals. Thus we
conclude that ACBP is necessary for intact urine concentrating ability.
Our data suggest that the deficiency in urine concentrating ability in
the ACBP/ may be caused by reduced AQP3, leading to impaired
efflux over the basolateral membrane of the collecting duct.
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THE ACYL-COA BINDING PROTEIN (ACBP)/diazepam binding inhib-
itor (DBI) is a small intracellular protein that binds and
transports medium and long-chain acyl-CoA (LC-CoA) esters
with a preference for carbon chain lengths C14–C22 (24) and
with a 1:1 binding stoichiometry. The protein is believed to
transport acyl-CoA esters between different enzymatic sys-
tems, but the exact cellular and physiological roles of ACBP
are not well understood (7, 17). ACBP is ubiquitously ex-
pressed in eukaryotic cells, but lipogenic cell types and epi-
thelia express particularly high levels of the protein (3, 20).
We have recently shown that mice with targeted disruption
of the ACBP gene (ACBP/) are viable and fertile but display
delayed adaptation to weaning with delayed induction of he-
patic cholesterogenesis (19). In addition, it has been shown that
mice with the large chromosomal deletion nm1054, including
the ACBP gene, exhibit a characteristic skin and fur phenotype
with sparse, matted reddish hair, which has a greasy appear-
ance (14). We have recently found that this phenotype reca-
pitulates in ACBP/ mice and that this skin and fur pheno-
type includes a defective epidermal permeability barrier with a
50% increased transepidermal water loss (Bloksgaard M,
Bek S, Neess D, Brewer J, Marcher AB, Hannibal-Bach HK,
Helledie T, Ejsing CS, Fenger C, Due M, Chemnitz J, Finsen
B, Clemmensen A, Wilbertz J, Saxtorph H, Knudsen J, Baga-
tolli L, Mandrup S, unpublished observations).
ACBP has previously been reported to be expressed at high
levels in the renal epithelium in rats as well as in many other
epithelia (2, 3), indicating that ACBP may play an important
role in epithelial function. To investigate a potential role of
ACBP in renal epithelial function, we examined water and
NaCl balance in ACBP/ mice in metabolic cages under
standard conditions and subsequent to water deprivation. It was
specifically addressed whether the renal medullary osmotic
gradient and collecting duct aquaporins (AQPs) were affected
by disruption of ACBP. We show that ACBP is highly ex-
pressed along the murine and human renal tubular epithelium
and that its disruption in mice leads to attenuated urine con-
centrating ability. Our data suggest that this may be caused by
selective alterations in renal AQP abundance and membrane
insertions.
MATERIALS AND METHODS
Animal experiments. All in vivo experiments and animal handling
were approved by the Danish Animal Experiments Inspectorate under
the Danish Ministry of Justice and were in accordance with the
published guidelines from the National Institutes of Health. In the
metabolic cage experiments, male C57BL/6JBom mice and congenic
ACBP/ mice were used. ACBP/ mice were generated using a
targeted gene deletion approach leading to a nonfunctional ACBP
gene (19). The mice were housed at the Biomedical Laboratory,
University of Southern Denmark as described (19).
For experiments in metabolic cages, mice were allowed a 2-day
adaptation period, after which baseline water and food intake, diure-
sis, and fecal mass were determined for 2 days. Mice were then
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deprived of water for 20 h, and urine was collected after 4 and 20 h.
Mice were anesthetized using ketalar/rompun (0.1 ml/10 g) and
euthanized by heart puncture. Blood was collected in Li-heparin-
coated tubes, and plasma was isolated by centrifugation. Adrenal
glands and kidneys were weighed, and the papillas were isolated.
Tissue from control ACBP/ and / mice not housed in metabolic
cages was obtained after anesthesia using ketalar/rompun (0.1 ml/10
g) and exsanguination by heart puncture. All tissues were snap-frozen
in liquid nitrogen before storage at 80°C. Plasma and urine osmo-
lality was determined by freeze-point depression (Osmomat 030,
Gonotec, Bie and Berntsen). Na and K concentrations in plasma
and urine were determined by flame photometry (model IL 943,
Instrumentation Laboratory, Laboratories Scandinavia). Hematocrit
was determined using a hematocrit-centrifuge (Sigma). Water content
in feces and chow was determined by continuous drying at 105°C
until constant weight was achieved (20 h).
Osmolytes were extracted from papillas at baseline and after water
deprivation essentially as described (13, 26). The osmolality, Na,
K sodium, potassium, and urea concentration of the supernatants
was determined as described (26).
mRNA assays. Outer and inner medullary collecting ducts (OMCD
and IMCD, respectively) from wild-type mice (C57BL/6JBom) were
isolated, after which RNA was purified and subjected to RT-PCR
analysis (2). RNA was isolated from cultured cells using TRIzol
reagent (Invitrogen) according to the manufacturer’s instructions.
RNA concentration and quality were evaluated by use of a NanoDrop
1000 Spectrophotometer and gel electrophoresis. RNA was treated
with DNaseI (Invitrogen), and cDNA was synthesized as described
previously (9). For quantitative PCR, samples of 50 ng cDNA (in
duplicate) were used as a template, mixed with the respective primers
(Table 1) and iQ SYBR Green Supermix (Bio-Rad) or SYBR green
Jumpstart Taq Ready Mix (Sigma). The PCR reactions were run on
Stratagene Mx3000 (AH diagnostics) or iCycler (Bio-Rad). A stan-
dard curve was constructed by plotting a threshold cycle against a
serial dilution of plasmids or a purified PCR product of the gene of
interest.
Western blotting. Kidney tissue was homogenized and proteins
were separated by SDS-PAGE and blotted onto polyvinylidene diflu-
oride membranes as described previously (26). For AQP3 and AQP4,
identical gels were run in parallel and subjected to Coomassie staining
to ensure identical loading. M-1 cells were harvested in SDS lysis
buffer [2.3% SDS, 50 mM Tris·HCl, pH 6.8, 10% glycerol, 10 mM
DTT, 10 mM -glycerolphosphate, 10 mM sodium fluoride, 0.1 mM
sodium orthovanadate, 1 mM PMSF, and 1 complete protease
inhibitor (Boehringer Mannheim)], boiled, and treated with benzonase
(Merck). The membranes were incubated with primary antibody in
2–5% nonfat milk in PBS or TBS, 0.1% Tween 20 (room temperature,
1 h or 4°C overnight) and then incubated with secondary antibody in
2–5% nonfat milk in PBS or TBS (room temperature, 1 h). The
membranes were washed in PBS before ECL detection (Amersham
Pharmacia Biotech). The light emitted by the oxidized luminol was
detected by Kodak X-Omat UV film. Equal loading was confirmed by
amidoblack staining of the membrane and ECL detection of transcrip-
tion factor IIB (TFIIB).
The primary antibodies used were goat anti-AQP2 (sc-9882, Santa
Cruz Biotechnology), 1:1,000; rabbit anti-AQP3 (LL178AP, Water
and Salt Center, Aarhus, Denmark), 1:500; rabbit polyclonal anti-
AQP4 (AQP-004, Alomone), 1:1.000; rabbit polyclonal anti--actin
(ab8227, Abcam), 1:20.000; rabbit anti-ACBP (Institute of Biochem-
istry and Molecular Biology, Univ. of Southern Denmark), 1:1.500;
and rabbit anti-TFIIB C-18 (sc-225, Santa Cruz Biotechnology),
1:1,000. The secondary antibody used was horseradish peroxidase-
conjugated swine anti-rabbit IgG 1:1,000 (Dako). Expected sizes of
detected proteins are as follows: AQP2: 29 kDa, glycosylated AQP3:
27 kDa, nonglycosylated AQP3: 33-40 kDa, AQP4: 32 kDa, -actin:
42 kDa, ACBP: 10 kDa, and TFIIB: 33 kDa.
Immunohistochemistry. Anesthetized ACBP/ and / mice were
perfused through the left cardiac ventricle with PBS (1; 10,
GIBCO) for 1 min followed by 4% formaldehyde (Sigma) in PBS for
4 min. Organs were paraffin-embedded as described, and sections
were mounted on glass slides (26). The slides were deparaffinized in
3 tissue clearer (5 min each), rehydrated in a graded ethanol series
(99.9%¡ 70%, 3 min each), and left under running water for 5 min.
Immunohistochemistry was performed as described previously (26).
Epitope retrieval was performed by heating sections in a microwave
oven set at 850 W until boiling (5 min), followed by boiling at
3–400 W. Total heating time and buffers used for boiling are indi-
cated in parentheses for the individual primary antibodies. Primary
antibodies were rabbit anti-AQP1 (15080-25, Abcam), 1:500 in TBST
with 5% milk (20 min, Dako citrate buffer); goat anti-AQP2 (Sc-9882,
Table 1. Primers used for PCR and qPCR
Gene Primer Sequence Number of Steps and Cycles Product Size, bp Company
ACBP, PCR 5=-ttt-cgg-cat-ccg-tat-cac-ct-3= 3, 35 144 MWG
5=-atc-gcc-cac-agt-agc-ttg-tt-3= Biotech
ACBP, qPCR 5=-ttt-cgg-cat-ccg-tat-cac-ct-3= 3, 40 51 MWG
5=-ttt-gtc-aaa-ttc-agc-ctg-aga-ca-3= Biotech
ACBP, BMB 5=-ggg-caa-agc-caa-gtg-gg-3= 3, 40 51 DNA
5=-cct-tgg-aag-tcc-ctt-tca-gct-3= Technology
AQP1 5=-cat-cac-ctc-ctc-cct-agt-cg-3= 3, 44 102 MWG
5=-tgc-aga-gtg-cca-atg-atc-tc-3= Biotech
AQP2 5=-ctt-cct-tcg-agc-tgc-ctt-c-3= 3, 40 128 MWG
5=-cat-tgt-tgt-gga-gag-cat-tga-c-3= Biotech
CYP11b2 5=-gca-cca-ggt-gga-gag-tat-gc-3= 3, 40 150 MWG
5=-gac-agc-aca-ttt-cgg-ttc-ag-3= Biotech
NKCC2 5=-cat-ggc-att-cat-tct-cat-cg-3= 3, 44 109 MWG
5=-ata-cga-ggc-atg-gaa-aca-gg-3= Biotech
P450 scc 5=-ctg-cct-cca-gac-ttc-ttt-cg-3= 3, 40 141 MWG
5=-ctg-gct-gaa-gtc-tcg-ctt-ct-3= Biotech
Renin 5=-gct-atg-tga-aga-agg-ctg-3= 2, 44 112 Invitrogen
5=-ttc-tct-tct-cct-tgg-ctc-3=
TBP 5=-cag-cct-tcc-acc-tta-tgc-tc-3= 2, 44 169 MWG
5=-ttg-ctg-ctg-ctg-tct-ttg-tt-3= Biotech
TFIIB 5=-gtt-ctg-ctc-caa-cct-ttg-cct-3= 3, 40 51 MWG
5=-tgt-gta-gct-gcc-atc-tgc-act-t-3= Biotech
ACBP, acyl-CoA binding protein; AQP1, aquaporin-1; AQP2, aquaporin-2; CYP11b2, aldosterone synthase; NKCC2, Na-K-2Cl cotransporter; P450 scc,
cholesterol side-chain cleavage enzyme; TBP, TATA box binding protein; TFIIB, transcription factor IIB.
F1035ACBP/ MICE DISPLAY ATTENUATED URINE CONCENTRATING ABILITY
AJP-Renal Physiol • doi:10.1152/ajprenal.00371.2011 • www.ajprenal.org






Fig. 1. Localization of the acyl-CoA binding protein
(ACBP) in murine and human kidney. A–D: immu-
nohistochemical staining of kidney sections from
wild-type (/), mice with antiserum directed against
ACBP. In the cortex, ACBP was located in proximal
tubules, distal tubules, collecting ducts, and Bow-
man’s capsule (A). In the outer medulla, immunola-
beling was associated with the loop of Henle, pre-
sumably the thick ascending limb, and with collect-
ing ducts. Vascular bundles were not immunopositive
(B). In the inner medulla, ACBP was restricted to
collecting ducts (C and arrowhead in D). Adipocytes
associated with the renal hilus were strongly labeled
for ACBP (C). Specificities of antibodies were con-
firmed by replacing ACBP antiserum with buffer (E)
and by staining sections from ACBP/ (KO) mice
(F). G: qualitative PCR analysis for ACBP in med-
ullary collecting ducts from ACBP/ mice. ACBP
was expressed in outer and inner medullary collecting
ducts (MCD). Amplification of aquaporin-2 (AQP2)
mRNA confirmed that the microdissected segments
were identified correctly as collecting ducts (bottom).
Addition of water instead of cDNA and the absence
of reverse transcriptase (RT) were used as negative
controls. Whole kidney was used as a positive control
(Ctrl). H–J: immunohistochemical staining of human
kidney sections with antiserum directed against
ACBP. In the renal cortex, proximal convoluted tu-
bules (H), Bowman’s capsule, intraglomerular cells,
and distal nephron epithelium (I) displayed immuno-
histochemical signal. In human kidney outer medulla,
ACBP immunoreactive protein was associated with
collecting ducts. Magnification 10 in A–C, E, and
F; bars  200 m and 40 in D and H–J; bars 
50 m.
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Santa Cruz Biotechnology), 1:200 in diluting buffer (S2022, 20 min,
TRS); rabbit anti-pAQP2 (KO407, The Water and Salt Center, Aarhus
University), 1:1,000 in PBS with 1.5% BSA and 0.3% Triton X-100
(20 min, TEG); rabbit anti-AQP3 (The Water and Salt Center, Aarhus
University), 1:200 in PBS with 0.1% BSA and 0.3% Triton X-100 (10
min, TEG); rabbit anti-AQP4 (AQP-004, Alomone), 1:1,000 in PBS
with 0.1% BSA and 0.3% Triton X-100 (10 min, TEG); rabbit
anti-mouse ACBP (Institute of Biochemistry and Molecular Biology,
Univ. of Southern Denmark), 1:500 in TBS with 10% FCS (20 min,
TEG); rabbit anti-human ACBP (Institute of Biochemistry and Mo-
lecular Biology, Univ. of Southern Denmark), 1:200 in TBST with
1.5% goat-serum (20 min, TEG); and mouse anti-E-cadherin (BD
Bioscience), 1:2,000 in TBST with 1.5% BSA (20 min, TEG).
Plasma hormone analysis. Plasma corticosterone was measured by
competitive immunoassay with a Correlate-EIA Corticosterone kit
(Assay Designs) according to the manufacturer’s instructions. The
optical density was determined at 405 nm using an Elisa plate reader
(Versa Max microplate reader, Molecular Devices). Plasma renin
concentration was analyzed as described previously (22). Plasma
aldosterone was measured with a commercial kit (COAT-A-COUNT,
Diagnostic Products, Los Angeles, CA) according to the manufactur-
er’s instructions. cAMP in urine was measured with the cAMP EIA kit
(Cayman Chemical) according to the manufacturer’s instructions.
Knockdown of ACBP in M-1 kidney epithelial cells. Lentiviral
particles for knockdown of ACBP [TRCN0000105050 and TRCN
0000105053 MISSION short hairpin (sh) RNA plasmids (Sigma-
Aldrich)] were generated in HEK293T cells according to the manu-
facturer’s instructions. LacZ lentiviral particles were prepared in
parallel and used as a negative control. M-1 mouse cortical collecting
duct cells (American Type Culture Collection, Borås, Sweden) were
transduced with the three different lentivira. Two days posttransduc-
tion, cells were selected by puromycin and grown for 2 additional
days. The cells were trypsinized and plated with a density of 2.5 
105 cells/ml in the filter inserts of six-well Transwell plates (Costar)
and grown for 10 days on the filter inserts in the presence of
puromycin. Cells were cultured in DMEM:F12 with L-glutamine and
15 mM HEPES (GIBCO) supplemented with 5% FCS (GIBCO) and
5 M dexamethasone (Sigma), penicillin, and streptomycin (Sigma).
Transepithelial resistance was measured by use of the EVOM voltage
and ohm meter with chopstick electrodes (World Precision Instru-
ments) for each knockdown cell line in four replicates. Cells were
harvested for analyses of RNA and protein expression of ACBP on the
same days as resistance measurements.
Statistics. All results are presented as means  SE. All statistical
tests were performed using GraphPad Prism 5.02. Two groups were
compared by an unpaired Student’s t-test. For multiple comparisons,
one-way ANOVA was used followed by a post hoc Bonferroni
multiple comparison test. If data did not have a Gaussian distribution,
a nonparametric Mann-Whitney test was used. P 	 0.05 (*) was
considered statistically significant. P 	 0.01 and P 	 0.001 were
marked as ** and ***, respectively, in figures and tables.
RESULTS
ACBP localizes identically along the nephron of mouse and
human kidney. Previous investigations have shown that ACBP
is expressed in the renal epithelium in rats (3). To obtain
further insight into the cell type-specific distribution of ACBP
in the kidney, immunohistochemical labeling of mouse and
human kidney sections with an ACBP antiserum was per-
formed. This resulted in immunopositive mouse kidney sec-
tions, which displayed widespread localization of immunore-
active protein along virtually all nephron parts (Fig. 1). The
ACBP labeling was more intensive in the cortex than in the
medulla and was associated strongly with proximal convoluted
and straight tubules, but observed also in distal tubules, col-
lecting ducts, and Bowman’s capsule (Fig. 1A). The cortical
vasculature (glomeruli, arteries) was not immunopositive (Fig.
1A). In the outer medulla, virtually all nephron segments were
immunopositive for ACBP (descending and ascending limbs of
the loop of Henle and collecting ducts) while vascular bundles
were negative (Fig. 1B). In the inner medulla, ACBP was
detected in the collecting ducts with faint signals from thin
limbs and no signal from medullary capillaries (Fig. 1, C and
D). Adipocytes associated with the renal hilus were strongly
labeled for ACBP (Fig. 1C), in keeping with previous data
showing high expression of ACBP in adipocytes (10, 20).
Antibody specificity was confirmed by omitting a primary
antibody (Fig. 1E) and by using kidney sections from
ACBP/ mice (Fig. 1F). Of note, ACBP/ kidneys exhib-
ited no structural injury: cysts, glomerular sclerosis, papillary
atrophy, cortical thinning, or inflammation (Figs. 1F) (3, 5, 7).
Local expression of ACBP mRNA was detected in microdis-
sected collecting ducts by RT-PCR (Fig. 1G). Human kidney
sections exhibited a grossly similar distribution of ACBP-
immunoreactive protein to that of mouse kidney (Fig. 1, H–J).
Thus a uniform signal was associated with proximal convo-
luted and straight tubules (Fig. 1H), Bowman’s capsule (Fig.
1I), intraglomerular cells (Fig. 1I), and distal nephron segments
(Fig. 1I) and with cortical and medullary (Fig. 1J) collecting
ducts. Labeling of cortical vs. medullary epithelium was more
even compared with mouse kidney (Fig. 1, H–J).
ACBP/ mice exhibit increased water intake and diuresis.
To investigate the effect of ACBP on whole body turnover of
water, food, and electrolytes, we used metabolic cages to
determine food and water intake, fecal excretion, and diuresis
Table 2. Characteristics of ACBP/ mice and ACBP/
mice under baseline conditions and upon water deprivation
Baseline ACBP/ ACBP/
Water intake, ml  day1  25-g mouse1 4.3  0.2 5.4  0.3**
Food intake, g  day1  25-g mouse1 3.7  0.1 3.7  0.2
Diuresis, ml  day1  25-g mouse1 1.66  0.1 2.17  0.2*
Urine osmolality, mosmol/l 2,608 95 2,278  135
Wet fecal mass, g  day1  25 g-mouse1 1.80  0.1 1.91  0.2
Water in feces, ml  day1  25-g mouse1 0.80  0.1 0.84  0.1
Na excretion, mmol  day1  25-g
mouse1 0.19  0.02 0.23 0.02
K excretion, mmol  day1  25-g mouse1 0.70  0.04 0.72 0.05
Papillary [Na], mmol/l 163.0  22 186.4  58
Papillary [K], mmol/l 80.1  6.8 80.0  9.4
Water deprivation ACBP/ ACBP/
Food intake, g  20 h1  25-g mouse1 3.1  0.1 3.4  0.1
Wet fecal mass, g  20 h1  25-g mouse1 1.46  0.1 1.61  0.1
Water in feces, ml  20 h1  25-g mouse1 0.54  0.1 0.61  0.1
Na excretion, mmol  day1  25-g mouse1 0.18  0.02 0.16 0.02
K excretion, mmol  day1  25-g mouse1 0.68  0.03 0.72 0.02
Plasma osmolality, mosmol/l 330.9 2.5 335.2 6.0
Plasma Na, mmol/l 144.0  2.4 142.7 3.3
cAMP excretion, nmol  16 h1  25-g
mouse1 21.9  1.8 26.8  1.9
Kidney weight/body weight, mg/g 12.84  0.2 13.03 0.3
Adrenal gland weight/body weight, mg/g 0.26  0.02 0.29 0.02
Papillary [Na], mmol/l 255.9  16.4 236.3 16.2
Papillary [K], mmol/l 86.9  2.18 94.5 3.0
Papillary [Urea], mmol/l 436.4 31.1 466.4 35.4
Values are means  SE. Brackets indicate concentration. Significant differ-
ences between groups are marked with asterisks. *P 	 0.05. **P 	 0.01; n 
6–12.
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in / and ACBP/ mice. Interestingly, water intake and
diuresis during standard conditions were significantly higher in
ACBP/ mice compared with / mice, while urine osmola-
lity was not significantly different (Table 2). Food intake, wet
fecal mass, water content in feces, and excretion of Na and
K in urine did not differ between genotypes (Table 2).
Furthermore, adrenal and kidney weights related to body
weight were similar between the two groups under standard
conditions (Table 2). Importantly, when subjected to water
deprivation for 20 h, ACBP/ mice exhibited a less reduced
diuresis and reached a lower level of urine osmolality com-
pared with / mice (Fig. 2, A and B). Water deprivation
resulted in elevation of hematocrit (Fig. 2C) and a more
pronounced relative whole body weight loss in ACBP/
compared with / mice (Fig. 2D). Plasma osmolality and
plasma Na concentrations rose equally for ACBP/ and /
mice during water deprivation (Table 2). After water depriva-
tion, food intake, feces excretion, Na and K excretion in
urine, and water content in feces did not differ between
genotypes (Table 2). These results indicate that ACBP/ mice
exhibit attenuated urine concentrating ability, without altera-
tions in dipsogenic behavior or intestinal water handling.
ACBP/ mice have normal medullary interstitial osmolality. To
investigate whether the urine concentration defect was caused
by a decreased ability to generate a hyperosmotic medullary
interstitium, we analyzed medullary osmolality and mRNA
expression of transport proteins which are crucial for estab-
lishing the single effect. Normohydrated ACBP/ and
ACBP/ mice exhibited no difference in inner medullary
interstitial osmolality (Fig. 3A). After water deprivation, both
ACBP/ and ACBP/ mice exhibited a significant increase
in papillary interstitial fluid osmolality (Fig. 3A). There was no
difference in osmolality between genotypes after water depri-
vation (Fig. 3A). In normohydrated ACBP/ and / mice,
concentrations of Na and K in inner medullary interstitium
showed no difference (Table 2). After water deprivation, med-
ullary interstitial fluid concentrations of urea, Na, and K in
ACBP/ were not different from ACBP/ mice (Table 2).
Furthermore, the renal mRNA level of the Na-K-2Cl cotrans-
porter (NKCC2) and the water channel AQP1 did not differ
significantly between ACBP/ and / mice (Fig. 3, B and
C). The distribution and labeling intensity of AQP1 in water-
deprived ACBP/ were comparable to / mice as deter-
mined by immunostaining (Fig. 3D). Thus ACBP is not re-
quired to maintain tissue abundance of transporters necessary
for establishment of the longitudinal medullary interstitial
gradient. Consistent with this, ACBP/ and / mice dis-
played no differences in interstitial osmolality in papillas.
The renin-angiotensin-aldosterone system is intact in
ACBP/ mice. Since adrenal steroids are necessary for urine
concentrating ability and ACBP has been shown to support the
synthesis of steroids at several levels (21), we determined the
expression of the rate-limiting enzyme P450scc and the plasma
concentration of steroids in ACBP/ and / mice. The
adrenal mRNA level of the cholesterol side-chain-cleavage
enzyme was not significantly different between ACBP/ and
/ mice (Fig. 4A), whereas the expression of aldosterone
synthase (CYPB11) was significantly elevated in the ACBP/
mice (Fig. 4B). The kidney cortex renin mRNA level and
plasma renin concentration did not differ between genotypes
(Fig. 4, C and D). Plasma concentrations of corticosterone and
aldosterone in ACBP/ mice were not different from
ACBP/ (Fig. 4, E and F). Thus disruption of ACBP does not
attenuate the renin-angiotensin-aldosterone system or mainte-
nance of circulating glucocorticoid in vivo.
Effect of ACBP deletion on renal collecting duct AQPs.
Urine concentrating ability depends on water reabsorption
across the collecting duct epithelium. Therefore, we examined
Fig. 2. ACBP/ mice display significantly attenu-
ated urine concentrating ability after water depriva-
tion. The urine concentrating ability of ACBP/
(KO; n  11) and / (WT; n  12) mice following
water deprivation (20 h) was determined in metabolic
cages. A: ACBP/ mice displayed a significantly
larger diuresis compared with / mice after water
deprivation. *P 	 0.05. B: ACBP/ mice exhibited
significantly attenuated maximal urine osmolality
compared with / mice after water deprivation.
**P 	 0.01. C: ACBP/ mice had a significantly
higher hematocrit after water deprivation compared
with / mice. **P 	 0.01. D: ACBP/ mice had
significantly higher relative weight loss in response to
water deprivation compared with WT mice ***P 	
0.001.
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expression of the three major collecting duct aquaporins,
AQP2, -3, and -4 in the kidneys from ACBP/ and / mice.
Both normohydrated and water-deprived ACBP/ mice
showed expression of AQP2 mRNA and protein that was not
different from / mice. Of note, both nonglycosylated AQP2
(29 kDa) and glycosylated AQP2 (35 kDa) protein did not
display any difference in abundance (Fig. 5, A–C) between
genotypes and water regimens. At baseline and under water-
deprived conditions, immunohistochemical analyses of total
AQP2 showed no distinct difference in the immunolabeling
intensity or distribution in the collecting duct principal cells
between ACBP/ and / mice (Fig. 5D). Since phosphory-
lation of AQP2 at serine 256 is necessary for apical trafficking
and insertion of AQP2 in the plasma membrane, we performed
immunolabeling of kidney tissue for phospho-S256 AQP2
(pAQP2). As shown in Fig. 5E, no reduced abundance of
pAQP2 was associated with apical membranes of water-de-
prived ACBP/ mice compared with / mice (Fig. 5E).
Western immunoblotting for AQP3 showed a significantly
lower abundance of nonglycosylated AQP3 in the cortex/outer
medulla fraction (Fig. 6A). Immunohistochemical labeling of
AQP3 in kidney sections from water-deprived ABP/ mice
showed an association of AQP3 with the basolateral domain of
collecting duct cells in the cortex/outer medulla. Interestingly,
this association was less obvious in water-deprived ACBP/
mice (Fig. 6C). Measurement of the AQP4 protein level in
cortex/outer medulla tissue revealed no difference between
genotypes (Fig. 6B). Immunohistochemical detection of AQP4
showed association with basolateral membranes in collecting
ducts, particularly in the inner medulla. However, there were
Fig. 3. Disruption of ACBP does not affect the
longitudinal medullary osmotic gradient. A: determi-
nation of osmolality in papillary interstitial fluid of
normohydrated ACBP/ (n  7) and / (n  6)
mice and water-deprived (WD) ACBP/ (n  8)
and / (n  9) mice. In normohydrated mice, there
was no difference in osmolality between genotypes.
In the water-deprived state, papillary interstitial fluid
osmolality increased compared with normohydration
(#P 	 0.05) but with no difference between geno-
types. B and C: determination of renal mRNA levels
of transporters involved in generation of a hyperos-
motic medullary interstitium in ACBP/ (n  10)
and / (n 10) mice as determined by quantitative
PCR. Neither Na-K-2Cl cotransporter (NKCC2;
B) nor aquaporin-1 (AQP1; C) mRNA levels dif-
fered significantly between genotypes. mRNA level
is shown relative to TATA box binding protein
(TBP) mRNA level. D: immunohistochemical stain-
ing of kidney sections from ACBP/ and / mice
for AQP1. AQP1 was observed in proximal tubules,
descending thin limbs of Henle’s loop, and vasa recta.
There was no difference in labeling pattern between
genotypes as seen in the bottom micrographs. Specific-
ity was confirmed by omitting primary antibody (not
shown). Magnification 40; bar  50 m.
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no visible differences in AQP4 signal intensity or distribution
between the genotypes (Fig. 6D). There was no difference in
cAMP urine excretion between water-deprived ACBP/
and / mice (Table 2). Thus disruption of ACBP appears not
to affect short-term vasopressin signaling and AQP2 abun-
dance and trafficking in the collecting duct, while AQP3 and
basolateral water transport appear to be the culprit.
ACBP is dispensable for formation of the epithelial barrier
in vitro. The capacity for regulation of water reabsorption
depends on transcellular transport and an intact paracellular
cell barrier. We therefore tested the significance of ACBP for
maintenance of tight junctions in cultured cortical collecting
duct cells (M-1 cell line). shRNA-mediated knockdown of
ACBP was effective, both at the mRNA and protein level
(Fig. 7, A and B). M-1 cells with knockdown of ACBP
achieved a transepithelial electrical resistance similar to
control cells (Fig. 7C). Immunohistochemical analyses of
kidneys from ACBP/ and / mice did not reveal any
difference in density and distribution of the major adherens
junction protein E-cadherin along the basolateral plasma
membranes (Fig. 7D). We therefore conclude that ACBP is
unlikely to be necessary for paracellular barrier function in
collecting ducts.
DISCUSSION
In this study, we show that ACBP is widely associated with
the renal epithelium in both human and murine kidney. Tar-
geted disruption of the ACBP gene led to a significantly higher
water turnover rate at baseline and an increased renal, but not
fecal, water loss and more pronounced signs of systemic
dehydration upon water deprivation. We observed no morpho-
logical differences between kidneys of ACBP/ and /
mice, and the ability to set an interstitial medullary osmotic
gradient was intact in ACBP/ mice. No significant changes
in plasma concentrations of glucocorticoid, aldosterone, or
renin were detected. Interestingly, however, we observed a
lower abundance of renal AQP3 in ACBP/ mice compared
with /. ACBP is necessary to attain maximal renal conser-
vation of water, most likely through effects on basolateral
water exit in collecting ducts.
Similar to rat kidney (3), intense immunohistochemical
labeling signal for ACBP of the renal cortex and especially the
convoluted and initial straight portion of the proximal tubule
was noted in the murine kidney. The medulla, including the
collecting ducts, showed weaker signals. The human kidney
exhibited essentially a similar intrarenal distribution of ACBP.
Because ACBP mRNA was observed in microdissected tu-
bules, the immunohistochemical signals likely reflect local
expression and not uptake from tubular fluid. ACBP is also
highly expressed in the steroid hormone producing fasciculata
and glomerulosa cells in the adrenal gland (3), and reports
indicate that ACBP/DBI stimulates steroidogenesis (21). Im-
paired adrenal function with insufficient plasma levels of
adrenal steroids results in decreased urine concentrating ability
(4, 12, 23). ACBP/ mice displayed no difference in baseline
plasma renin, aldosterone, and corticosterone concentrations
compared with / mice. Thus our data indicate that ACBP
does not play an important role in adrenal steroid production.
We did, however, observe an increased aldosterone synthase
expression in the adrenal gland (CYPB11) of ACBP/ com-
pared with / mice, and we cannot exclude that this is part of
a compensatory mechanism that maintains a normal steroid
production in the absence of ACBP. The data show that
insufficient synthesis and secretion of adrenal steroids is an
unlikely cause for the attenuated urine concentrating ability.
Fig. 4. Disruption of ACBP and activity of the renin-angiotensin-aldosterone
system. A and B: tissue mRNA level of enzymes in steroid hormone production
determined by quantitative PCR in ACBP/ (n  10) and / (n  10) mice
adrenals. mRNA level is shown relative to TBP mRNA level. No difference in
mRNA level of cholesterol side-chain cleavage enzyme (P450scc) was ob-
served (A), whereas ACBP/ mice displayed a significantly elevated adrenal
mRNA level of aldosterone synthase (CYP11b2; B). *P 	 0.05. C: kidney
tissue renin mRNA level was not different between ACBP/ (n  10)
and / (n  10). mRNA level is shown relative to TBP mRNA level.
D: plasma concentration of renin in ACBP/ (n  5) and / (n  14) mice
was not significantly different. E: plasma concentration of corticosterone was
not significantly different between ACBP/ (n  8) and / (n  11) mice
(P 	 0.06). F: plasma concentrations of aldosterone were not significantly
different between ACBP/ (n  8) and / (n  8) mice (531  39 vs.
429  46 pg/ml).
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The comparable dimensions of the renal cortex-papilla axis,
the absence of macro- and microscopic renal injury, and the
normal kidney/body weight ratios in ACBP/ mice are con-
sistent with the ability to set a longitudinal medullary intersti-
tial fluid osmotic gradient and achieve elevated interstitial fluid
concentration of sodium and urea in ACBP/ mice. The
osmolality measured in the renal medullary interstitium was
not at equilibrium with urine. This discrepancy is likely caused
by a combination of overestimated urine osmolality caused by
evaporation during urine collection in metabolic cages for20
h and underestimation of the interstitial osmolality since more
tissue is included than the very tip of the papilla with highest
osmolality. The sum of urea, Na and K concentration with
accompanying anions accounted fully for the measured inter-
stitial osmolality, which suggests that dominant osmolytes are
quantitatively extracted from tissue. Because of the measured
Fig. 5. AQP2 and p256-AQP2 in ACBP/
mice and / controls. A and B: renal
mRNA level of AQP2 in ACBP/ and /
as determined by quantitative PCR. AQP2
mRNA level did not differ between the
genotypes in the normohydrated state
[ACBP/ (n  10), ACBP/ (n  10;
A)] and in the water-deprived state
[ACBP/ (n  9), ACBP/ (n  8; B)].
mRNA level is shown relative to TBP
mRNA level and the transcription factor
IIB (TFIIB) mRNA level. C: glycosylated
and nonglycosylated AQP2 protein level as
determined by Western immunoblotting in
homogenates from cortex and outer me-
dulla from water-deprived ACBP/ (n  8)
and / ( n  9) mice. Protein abundance of
AQP2 moieties was not different between ge-
notypes. AQP2 protein abundance is shown
relative to -actin protein abundance. D: immu-
nohistochemical labeling of mouse kidney sec-
tions from ACBP/ mice and / mice for
total AQP2. There was no obvious difference in
the labeling intensity or cytoplasmic distribu-
tion of AQP2 in the principal cells when
ACBP/ mice are compared with ACBP/
in the normohydrated (NH) and in the water-
deprived (WD) state. Specificity was confirmed
by omitting a primary antibody (not shown).
Magnification 40; bars  50 m. E: immu-
nohistochemical labeling of mouse kidney sec-
tions from water-deprived ACBP/ and /
mice for phospho-AQP2 (S256). ACBP/
mice did not display a lower density of pAQP2
in the apical membrane compared with /
mice. Specificity was confirmed by omitting a
primary antibody (not shown). Magnification
40; bars  50 m.
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gap in osmolalities between medullary tissue and urine, it
cannot be safely concluded that ACBP/ mice can achieve
the same maximal interstitial osmolality as / mice. Although
the data do not exclude that lack of ACBP impairs the ability
to achieve maximal medullary interstitial osmolality, the iden-
tical interstitial osmolality measured in the kidney of
ACBP/ and / mice indicates that the defect should be
found in the collecting duct.
Total AQP2 protein abundance was not changed in
ACBP/ mice, and immunostaining for phospho-S256-AQP2
showed no decrease in apical membrane association in water-
deprived ACBP/ compared with / mice. Although indi-
rect, these observations imply that vasopressin signaling and
vesicular trafficking of AQP2 are not compromised in collect-
ing duct cells by disrupting ACBP, as was observed in yeast
cells (6, 8). This notion was supported by the observation of
similar urinary excretion of cAMP. Thus the defect in urinary
concentrating capacity is less likely to be caused by decreased
abundance or membrane association of AQP2. AQP3 and -4
mediate basolateral water exit in collecting ducts and contrib-
ute to urine concentrating capacity (5, 16). Interestingly, we
observed that nonglycosylated AQP3 abundance was signifi-
cantly lower in ACBP/ mice than in / mice, indicating a
decreased ability for basolateral water and glycerol transport in
collecting ducts from ACBP/ mice. It is unclear what
causes this decrease in AQP3 expression. Of note, AQP3
Fig. 6. Effect of ACBP disruption on AQP3
and AQP4 in the kidney. A and B: AQP3 and
AQP4 protein levels as determined by West-
ern immunoblotting in homogenates obtained
with cortex/outer medulla tissue from water-
deprived ACBP/ (n  9) and ACBP/
(n  8) mice. Protein abundance of nongly-
cosylated AQP3 isoform was lower in
ACBP/ compared with / mice (A; *P 	
0.05). Tissue AQP4 protein abundance was
not different between genotypes (B). Protein
abundance is shown relative to -actin protein
abundance. C: immunohistochemical labeling
of mouse kidney sections from ACBP/
mice and / mice for AQP3. Labeling was
associated with basolateral membranes of col-
lecting duct principal cells, predominantly in
the cortex (COR) and outer medulla (OM). Sig-
nal intensity and cytoplasmic distribution were
less pronounced in ACBP/ compared with
/ mice. Glo, glomerulus. D: AQP4 was asso-
ciated predominantly with inner medulla (IM)
collecting duct cell basolateral membranes. No
difference in labeling intensity or distribution
was apparent between genotypes.
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null mice can to some degree increase their urine osmolality
after water deprivation despite polyuria and low urine os-
molality at baseline (16). Therefore, the present observation
of a modest reduction in AQP3 abundance is in accordance
with the mild phenotype.
Sphingolipids/ceramides are required for transport of gly-
cosyl-phosphatidylinositol (GPI)-anchored proteins from
the endoplasmic reticulum to Golgi, for fusion of vesicles
containing these proteins within Golgi (11, 27), and for
GPI-anchored protein sorting (18). GPI-anchored serine
proteases are important for epithelial barrier function in the
epidermis (15) and in collecting duct epithelium (M-1 cell
line) in vitro (25). Interestingly, Acb1p depletion in yeast
resulted in reduced sphingolipid levels (8). However,
knockdown of ACBP in M-1 cells did not impair transepi-
thelial electrical resistance development in vitro, and the
adherens junction protein E-cadherin showed no change in
abundance or distribution in ACBP/ mice in vivo. This
finding implies an intact paracellular integrity in the ACBP-
depleted cells consistent with the intact interstitial osmotic
gradient in ACBP/ mice.
In summary, the present data show that ACBP is strongly
associated with proximal nephron parts and collecting ducts
in mouse and human kidney and that ACBP is necessary for
maintenance of normal levels of renal AQP3 abundance and
for maximal urine concentrating ability. Thus these findings
indicate that disruption of ACBP attenuates basolateral
water efflux in renal collecting ducts.
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Fig. 7. ACBP knockdown does not impair establishment of tight junctions
in collecting duct cells in vitro. A and B: the short hairpin (sh) RNA-
mediated knockdown of ACBP in murine cortical collecting duct (M-1)
cells was highly efficient at both the mRNA level as determined by
quantitative PCR (days indicate days following seeding; A) and protein
level as determined by Western blotting (B). ACBP KD50 and 53 indicate
two different targeting constructs, whereas LacZ is the control shRNA-
expressing construct. C: measurements of transepithelial electrical resis-
tance. M-1 cells with knockdown of ACBP display no difference in
transepithelial electrical resistance 10 days after seeding, i.e., when the
epithelial barrier has formed and stabilized, compared with control cells.
D: immunohistochemical labeling of mouse kidney sections from ACBP/ and /
mice for E-cadherin. There was no difference in labeling intensity or
distribution in the plasma membrane between ACBP/ mice and /
mice. Specificity was confirmed by omitting a primary antibody (not
shown). Magnification 40; bars  50 m.
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